Hyperpolarized [1-13C]-Pyruvate MRI Differentiates Benign Fibroma From High-grade Serous Carcinoma.

Clin Nucl MedAug 3, 2026 (epub)

Malene Aastrup, Esben Søvsø Szocska Hansen, Katrine Fuglsang et al.

✦ AI-curated · Sources linked

Case in brief

Two women with suspected ovarian cancer underwent preoperative imaging using hyperpolarized [1-13C]-pyruvate MRI and FDG PET/CT. The first patient, with a right adnexal mass, showed limited FDG uptake and minimal lactate production, leading to a diagnosis of benign fibroma. The second patient exhibited extensive metabolically active tumors on FDG PET/CT, with hyperpolarized imaging revealing high lactate-to-pyruvate conversion, confirming high-grade serous carcinoma.

Diagnostic / clinical pearl

Hyperpolarized [1-13C]-pyruvate MRI can effectively differentiate between benign and malignant adnexal masses by assessing tumor glycolytic activity.

Why it matters

This case highlights the potential of hyperpolarized MRI as a complementary tool to traditional imaging methods in the preoperative evaluation of ovarian masses.

Source

Published in Clin Nucl Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.